Literature DB >> 23801191

Resolution of diabetic papillopathy with a single intravitreal injection of bevacizumab combined with triamcinolone acetonide.

Jing Feng1, Jin-Feng Qu, Yan-Rong Jiang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23801191     DOI： 10.1007/s00417-013-2403-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  6 in total

1.  Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab.

Authors:  Anne Willerslev; Inger Christine Munch; Michael Larsen
Journal:  Acta Ophthalmol       Date:  2012-01-23       Impact factor: 3.761

2.  Bilateral diabetic papillopathy and metabolic control.

Authors:  Christoffer Ostri; Henrik Lund-Andersen; Birgit Sander; Ditte Hvidt-Nielsen; Michael Larsen
Journal:  Ophthalmology       Date:  2010-06-16       Impact factor: 12.079

3.  Periocular corticosteroids in diabetic papillopathy.

Authors:  A M Mansour; M A El-Dairi; M A Shehab; H K Shahin; J A Shaaban; S R Antonios
Journal:  Eye (Lond)       Date:  2005-01       Impact factor: 3.775

4.  Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.

Authors:  Christiane E Al-Haddad; Fadi A Jurdi; Ziad F Bashshur
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

5.  Response of diabetic papillopathy to intravitreal bevacizumab.

Authors:  Hassan Al-Dhibi; Arif O Khan
Journal:  Middle East Afr J Ophthalmol       Date:  2011-07

6.  Diabetic papillopathy with macular edema treated with intravitreal bevacizumab.

Authors:  Ahmed S Al-Hinai; Mohammed S Al-Abri; Rayah H Al-Hajri
Journal:  Oman J Ophthalmol       Date:  2011-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.